305 related articles for article (PubMed ID: 34025681)
21. Successful treatment with daratumumab, lenalidomide, and dexamethasone therapy followed by autologous stem cell transplantation for newly diagnosed polyneuropathy, organomegaly, endocrinopathy, M-protein, skin changes syndrome: a case report.
Taenaka R; Shimokawa S; Katayama A; Nagao T; Obara T; Nishimura N; Tsujimoto A; Kohno K; Aoki K; Ogawa R
J Med Case Rep; 2022 Aug; 16(1):311. PubMed ID: 35978379
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of lenalidomide in POEMS syndrome: a retrospective study of 20 patients.
Royer B; Merlusca L; Abraham J; Musset L; Haroche J; Choquet S; Leleu X; Sebban C; Decaux O; Galicier L; Roussel M; Recher C; Banos A; Guichard I; Brisseau JM; Godmer P; Hermine O; Deplanque G; Facon T; Asli B; Leblond V; Fermand JP; Marolleau JP; Jaccard A
Am J Hematol; 2013 Mar; 88(3):207-12. PubMed ID: 23335406
[TBL] [Abstract][Full Text] [Related]
23. Multiparameter Flow Cytometry for the Identification of Neoplastic Plasma Cells in POEMS Syndrome with IgG-kappa Gammopathy: Successful Treatment Using Lenalidomide and Dexamethasone.
Ikeda S; Kobayashi T; Saito M; Komatsuda A; Ubukawa K; Kameoka Y; Takahashi N
Intern Med; 2019 Dec; 58(23):3461-3468. PubMed ID: 31391391
[TBL] [Abstract][Full Text] [Related]
24. Raynaud's phenomenon and positive antinuclear antibodies as first manifestation of POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes): a case report.
Torres-Saavedra F; León-Sierra L
BMC Rheumatol; 2022 May; 6(1):26. PubMed ID: 35585632
[TBL] [Abstract][Full Text] [Related]
25. POEMS syndrome: diagnostic delay and successful treatment with lenalidomide, cyclophosphamide and prednisone followed by autologous peripheral stem cell transplantation.
Ordway S; Gilbert L; Wanko S
BMJ Case Rep; 2018 Jul; 2018():. PubMed ID: 30054320
[TBL] [Abstract][Full Text] [Related]
26. Pachymeningeal involvement in POEMS syndrome: dramatic cerebral MRI improvement after lenalidomide therapy.
Briani C; Manara R; Lessi F; Citton V; Zambello R; Adami F
Am J Hematol; 2012 May; 87(5):539-41. PubMed ID: 22389216
[TBL] [Abstract][Full Text] [Related]
27. Surgical revascularization for quasi-moyamoya disease associated with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome: a case report and literature review.
Kubota Y; Hanaoka Y; Koyama JI; Takahashi Y; Katoh N; Iwaya M; Fujii Y; Ogiwara T; Horiuchi T
Nagoya J Med Sci; 2023 Feb; 85(1):141-149. PubMed ID: 36923610
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of low-dose lenalidomide plus dexamethasone in patients with relapsed or refractory POEMS syndrome.
Cai QQ; Wang C; Cao XX; Cai H; Zhou DB; Li J
Eur J Haematol; 2015 Oct; 95(4):325-30. PubMed ID: 25401269
[TBL] [Abstract][Full Text] [Related]
29. Successful treatment of POEMS syndrome with bortezomib and dexamethasone, combined with radiotherapy, and followed by autologous stem cell transplantation.
Ishii Y; Yamazaki E; Ishiyama Y; Yamamoto E; Hattori Y; Hagihara M; Tomita N; Ishigatsubo Y
Int J Hematol; 2013 Dec; 98(6):723-8. PubMed ID: 24166587
[TBL] [Abstract][Full Text] [Related]
30. Lenalidomide as frontline therapy in polyneuropathy, organomegaly, endocrinopathy, monoclonal protein and skin changes syndrome: a retrospective case series of eight patients.
Lestang E; Caristan A; Néel A; Graveleau J; Duhamel E; Masseau A; Connault J; Maisonneuve H; Le Gouill S; Blin N; Touzeau C; Moreau P; Hamidou M
Leuk Lymphoma; 2015 Jun; 56(6):1895-6. PubMed ID: 25347429
[No Abstract] [Full Text] [Related]
31. Improvement of thyroid function in POEMS syndrome after combination therapy of lenalidomide and dexamethasone.
Yang H; Zhao H; Huang X; Cao X; Zhou D; Li J
Leuk Lymphoma; 2019 Feb; 60(2):483-487. PubMed ID: 30407096
[TBL] [Abstract][Full Text] [Related]
32. [POEMS syndrome: Diagnosis, stratification, treatments].
Talbot A; Jaccard A; Arnulf B
Rev Med Interne; 2021 May; 42(5):320-329. PubMed ID: 33678446
[TBL] [Abstract][Full Text] [Related]
33. Daratumumab plus lenalidomide and dexamethasone for relapsed POEMS syndrome with bone plasmacytoma harboring 17p deletion.
Oyama T; Taoka K; Chiba A; Masamoto Y; Ikemura M; Honda A; Maki H; Kurokawa M
Int J Hematol; 2023 Mar; 117(3):463-467. PubMed ID: 36202948
[TBL] [Abstract][Full Text] [Related]
34. An update on the diagnosis and management of the polyneuropathy of POEMS syndrome.
Cerri F; Falzone YM; Riva N; Quattrini A
J Neurol; 2019 Jan; 266(1):258-267. PubMed ID: 30264176
[TBL] [Abstract][Full Text] [Related]
35. [Treatment of POEMS syndrome with lenalidomide and dexamethasone].
Goto A; Iyama S; Sugama Y; Yoshida M; Ibata S; Tatekoshi A; Fujita C; Kikuchi S; Ikeda H; Murase K; Takada K; Kato J; Kobune M
Rinsho Ketsueki; 2019; 60(4):308-313. PubMed ID: 31068561
[TBL] [Abstract][Full Text] [Related]
36. Lenalidomide-Induced Ischemic Cerebrovascular Disease in Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes Syndrome.
Mitsutake A; Matsumoto H; Hatano K; Irie K; Tsukada N; Hashida H
J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):e102-e103. PubMed ID: 29395638
[TBL] [Abstract][Full Text] [Related]
37. Thrombosis revealing POEMS syndrome. About a case.
Dumas C; Bienvenu FH; Hicks J; Weber E; Sève P
Ann Biol Clin (Paris); 2020 Apr; 78(2):195-197. PubMed ID: 32162605
[TBL] [Abstract][Full Text] [Related]
38. POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes) treated with autologous hematopoietic stem cell transplantation: a case report and literature review.
Arana C; Pérez de León JA; Gómez-Moreno G; Pérez-Cano R; Martín Hernández T
Am J Case Rep; 2015 Mar; 16():124-9. PubMed ID: 25726020
[TBL] [Abstract][Full Text] [Related]
39. Ocular findings in patients with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes syndrome.
Kaushik M; Pulido JS; Abreu R; Amselem L; Dispenzieri A
Ophthalmology; 2011 Apr; 118(4):778-82. PubMed ID: 21035860
[TBL] [Abstract][Full Text] [Related]
40. Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomised, double-blind, placebo-controlled trial.
Misawa S; Sato Y; Katayama K; Nagashima K; Aoyagi R; Sekiguchi Y; Sobue G; Koike H; Yabe I; Sasaki H; Watanabe O; Takashima H; Nishizawa M; Kawachi I; Kusunoki S; Mitsui Y; Kikuchi S; Nakashima I; Ikeda S; Kohara N; Kanda T; Kira J; Hanaoka H; Kuwabara S;
Lancet Neurol; 2016 Oct; 15(11):1129-37. PubMed ID: 27496680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
